id	author	title	date	pages	extension	mime	words	sentence	flesch	summary	cache	txt
cord-293367-0fe62h2f	Henderson, Lauren A.	American College of Rheumatology Clinical Guidance for Pediatric Patients with Multisystem Inflammatory Syndrome in Children (MIS‐C) Associated with SARS‐CoV‐2 and Hyperinflammation in COVID‐19. Version 1	2020-07-23		.txt	text/plain	6235	215	30	All rights reserved RECOVERY trial) report that low to moderate dose dexamethasone significantly reduced mortality in COVID-19 patients requiring mechanical ventilation; but was reported after voting had occurred.(90, 91) Based on these studies that suggest that patients with severe COVID-19 pneumonia may benefit from immunomodulation with glucocorticoids, the Task Force achieved moderate consensus that glucocorticoid treatment could be considered in pediatric patients with severe COVID-19 and signs of hyperinflammation. The first webinar was used to confirm the target audience for the guidance, which focuses on clinicians in North America managing pediatric patients with inflammatory syndromes related to recent or concurrent infections with SARS-CoV-2.	cache/cord-293367-0fe62h2f.txt	txt/cord-293367-0fe62h2f.txt
